191 related articles for article (PubMed ID: 1448662)
1. Chemotherapy of malignant gliomas: studies of the BTCG.
Shapiro WR
Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662
[TBL] [Abstract][Full Text] [Related]
2. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.
Shapiro WR; Green SB; Burger PC; Selker RG; VanGilder JC; Robertson JT; Mealey J; Ransohff J; Mahaley MS
J Neurosurg; 1992 May; 76(5):772-81. PubMed ID: 1564540
[TBL] [Abstract][Full Text] [Related]
3. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ;
J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039
[TBL] [Abstract][Full Text] [Related]
4. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
Fernández-Hidalgo OA; Vanaclocha V; Vieitez JM; Aristu JJ; Rebollo J; Gúrpide A; Aramendía JM; Moreno-Palanques R; Martín-Algarra S; Subirá ML; Brugarolas A
Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007
[TBL] [Abstract][Full Text] [Related]
5. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
6. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of supratentorial glioma with intracarotid cisplatin and intravenous carmustine].
Rebollo J; Martín-Algarra S; Bilbao I; Zubieta JL; Calvo FA; de Castro P; Pastor MA; Viteri C; Martínez Lage JM
Neurologia; 1990; 5(7):228-32. PubMed ID: 1963067
[TBL] [Abstract][Full Text] [Related]
8. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.
Dinapoli RP; Brown LD; Arusell RM; Earle JD; O'Fallon JR; Buckner JC; Scheithauer BW; Krook JE; Tschetter LK; Maier JA
J Clin Oncol; 1993 Jul; 11(7):1316-21. PubMed ID: 8315428
[TBL] [Abstract][Full Text] [Related]
9. Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A.
Hiesiger EM; Green SB; Shapiro WR; Burger PC; Selker RG; Mahaley MS; Ransohoff J; VanGilder JC; Mealey J; Robertson JT
J Neurooncol; 1995; 25(2):143-54. PubMed ID: 8543970
[TBL] [Abstract][Full Text] [Related]
10. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
Rajkumar SV; Buckner JC; Schomberg PJ; Reid JM; Bagniewski PJ; Ames MM; Cascino TL; Marks RS
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):969-75. PubMed ID: 9869217
[TBL] [Abstract][Full Text] [Related]
11. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
Chang CH; Horton J; Schoenfeld D; Salazer O; Perez-Tamayo R; Kramer S; Weinstein A; Nelson JS; Tsukada Y
Cancer; 1983 Sep; 52(6):997-1007. PubMed ID: 6349785
[TBL] [Abstract][Full Text] [Related]
12. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
Rajkumar SV; Buckner JC; Schomberg PJ; Cascino TL; Burch PA; Dinapoli RP
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):297-302. PubMed ID: 9457812
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
Fine HA; Wen PY; Maher EA; Viscosi E; Batchelor T; Lakhani N; Figg WD; Purow BW; Borkowf CB
J Clin Oncol; 2003 Jun; 21(12):2299-304. PubMed ID: 12805330
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial ACNU and carboplatin versus intravenous chemotherapy with cisplatin and BCNU in newly diagnosed patients with glioblastoma.
Silvani A; Eoli M; Salmaggi A; Erbetta A; Fariselli L; Boiardi A
Neurol Sci; 2002 Dec; 23(5):219-24. PubMed ID: 12522677
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
Prados MD; Larson DA; Lamborn K; McDermott MW; Sneed PK; Wara WM; Chang SM; Mack EE; Krouwer HG; Chandler KL; Warnick RE; Davis RL; Rabbitt JE; Malec M; Levin VA; Gutin PH; Phillips TL; Wilson CB
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):57-63. PubMed ID: 9422558
[TBL] [Abstract][Full Text] [Related]
16. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
West CR; Avellanosa AM; Barua NR; Patel A; Hong CI
Neurosurgery; 1983 Oct; 13(4):420-6. PubMed ID: 6314173
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with carmustine and cisplatin before, during, and after radiotherapy for adult malignant gliomas.
Kiu MC; Chang CN; Cheng WC; Lin TK; Wong CW; Tang SG; Leung WM; Chen LH; Ho YS; Ng KT
J Neurooncol; 1995; 25(3):215-20. PubMed ID: 8592171
[TBL] [Abstract][Full Text] [Related]
18. Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation.
Bobo H; Kapp JP; Vance R
J Neurooncol; 1992 Jul; 13(3):291-9. PubMed ID: 1517805
[TBL] [Abstract][Full Text] [Related]
19. Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.
Stewart DJ; Grahovac Z; Benoit B; Addison D; Richard MT; Dennery J; Hugenholtz H; Russell N; Peterson E; Maroun JA
Neurosurgery; 1984 Dec; 15(6):828-33. PubMed ID: 6392925
[TBL] [Abstract][Full Text] [Related]
20. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]